Dr. Carl H. June, whose original work was funded by ACGT, has expanded the number of patients who will benefit from his leukemia research. Current patients experiencing long remissions give the researchers hope that the treatment will have lasting effects.
Advancing molecular therapies for cancer
ACGT Newsletter
Donate to ACGT
